Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources
Share

Text Size

Small text Medium text Large text
 

A future without Alzheimer's

The race is on. Alzheimer's research is a dynamic field, and momentum builds each year. This site is for professional researchers and anyone interested in following the progress in research. The Alzheimer's Association has been involved in every major advancement in Alzheimer's research since the 1980's and is a leader in the global fight for a world without Alzheimer's.

 

what we know today

tomorrow's answers

clinical trials

 

Research Updates

spotlight

 

April 4, 2012

Drug Lowers Levels of Alzheimer’s Protein Tau
A small clinical trial shows the drug bapineuzumab lowers levels of the hallmark Alzheimer’s protein tau.  But whether it will improve disease symptoms is unknown.
> New Drug Might Reduce an Alzheimer’s Marker: Study
- HealthDay


March 20, 2012

DIAN Receives the Largest Research Grant in Association History
The Dominantly Inherited Alzheimer’s Network (DIAN) has been awarded a nearly $4.2 million grant from the Alzheimer’s Association, the largest research grant in Association history. The grant will support the Therapeutic Trials Unit (TTU) of DIAN, enabling DIAN-TTU to move forward more quickly with innovative drug and biomarker trials in people with genetically based, young-onset Alzheimer's disease.
> Alzheimer's Association Awards Nearly $4.2 Million to Accelerate Drug Trials
- Philanthropy News Digest
> Press Release
- Alzheimer's Association


March 15, 2012

Alzheimer’s Association Facts and Figures 2012
Alzheimer’s Association Facts and Figures is a comprehensive annual compilation of national statistics and information on Alzheimer’s and other dementias. The report conveys the impact of Alzheimer’s on individuals, families, government and the nation’s health care system. The 2012 edition reveals that health care costs for people with Alzheimer’s and other dementias are projected to reach $200 billion this year. The report includes a special feature on the challenges faced by the 800,000 Americans with Alzheimer’s who live alone.
> Access the 72-page report
> How to cite Alzheimer's Association Facts and Figures 2012
- Alzheimer's Association


February 9, 2012

Research In Mice, Cancer Drug Reduces Beta-Amyloid and Helps Memory
Bexarotene (Targretin), an oral drug approved by the FDA to treat a rare skin type of lymphoma, reduced beta-amyloid levels and improved memory and behavior in Alzheimer's mouse models. The Alzheimer's Association has funded much-needed additional research in this promising but preliminary area.
> ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
- Science
> Cancer drug shows promise in mouse Alzheimer's study
- The Washington Post



February 7, 2012

Obama Administration Dedicates New Resources to Alzheimer's Research
Secretary of Health and Human Services Kathleen Sebelius announced an additional $50 million for Alzheimer's research over the coming months, and an additional $106 million in the coming year to research, caregiver support and education.
> Administration announces new steps to fight Alzheimer's disease
- U.S. Department of Health and Human Services
>
Alzheimer's Association commends Obama administration for dedication of new resources to Alzheimer's
- Alzheimer's Associatio
n


ALL UPDATES


2012 Research Grant Program Announcement

Application procedures and key dates now available


Military Risk Factors for Alzheimer's Disease Meeting

May 8, 2012
Arlington, VA


Alzheimer's Association TrialMatch™

A free service to help connect people with clinical trials


World Wide Alzheimer's Disease Neuroimaging Initiative (ADNI)

A collaborative effort of scientists from around the world

get e-updates

 
  Zip:
Weekly e-news
Breaking research updates

you can help

Blog Facebook twitter flickr You Tube

 

 

Alzheimer's & Dementia Journal

 

Current Issue   |   May. 2012   |   Vol. 8, No. 3

ABOUT THE JOURNAL

   
 

Key awareness milestones


 

Key events during the past 100 years spurred public awareness of Alzheimer's disease and ignited a massive research effort to learn more.

See more milestones

 

Our research strategy

The Alzheimer's Association is committed to accelerating the global effort to eliminate Alzheimer's disease. We are the largest private, nonprofit funder of Alzheimer's research. We believe in the value of collaboration and are willing to imagine a time when we will have disease-modifying treatments, preventive strategies and gold-standard care for all people affected by Alzheimer's disease.

More about the Alzheimer's Association commitment to research.